These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12475782)

  • 21. 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase and small chemical activators affect enzyme activity of activating glucokinase mutants by distinct mechanisms.
    Langer S; Hofmeister-Brix A; Waterstradt R; Baltrusch S
    Biochem Pharmacol; 2019 Oct; 168():149-161. PubMed ID: 31254492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptation to hyperglycemia enhances insulin secretion in glucokinase mutant mice.
    Sreenan SK; Cockburn BN; Baldwin AC; Ostrega DM; Levisetti M; Grupe A; Bell GI; Stewart TA; Roe MW; Polonsky KS
    Diabetes; 1998 Dec; 47(12):1881-8. PubMed ID: 9836519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of high-fat diet on glucose homeostasis and gene expression in glucokinase knockout mice.
    Gorman T; Hope DC; Brownlie R; Yu A; Gill D; Löfvenmark J; Wedin M; Mayers RM; Snaith MR; Smith DM
    Diabetes Obes Metab; 2008 Sep; 10(10):885-97. PubMed ID: 18034843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic beta-cell-specific targeted disruption of glucokinase gene. Diabetes mellitus due to defective insulin secretion to glucose.
    Terauchi Y; Sakura H; Yasuda K; Iwamoto K; Takahashi N; Ito K; Kasai H; Suzuki H; Ueda O; Kamada N
    J Biol Chem; 1995 Dec; 270(51):30253-6. PubMed ID: 8530440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of glucokinase in glucose-unresponsive human fetal pancreatic islet-like cell clusters.
    Tu J; Tuch BE
    J Clin Endocrinol Metab; 1997 Mar; 82(3):943-8. PubMed ID: 9062511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A functional link between glucokinase binding to insulin granules and conformational alterations in response to glucose and insulin.
    Rizzo MA; Magnuson MA; Drain PF; Piston DW
    J Biol Chem; 2002 Sep; 277(37):34168-75. PubMed ID: 12101177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into mechanism of glucokinase activation: observation of multiple distinct protein conformations.
    Liu S; Ammirati MJ; Song X; Knafels JD; Zhang J; Greasley SE; Pfefferkorn JA; Qiu X
    J Biol Chem; 2012 Apr; 287(17):13598-610. PubMed ID: 22298776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved metabolic stimulus for glucose-induced insulin secretion through GK and PFK-2/FBPase-2 coexpression in insulin-producing RINm5F cells.
    Baltrusch S; Langer S; Massa L; Tiedge M; Lenzen S
    Endocrinology; 2006 Dec; 147(12):5768-76. PubMed ID: 16980436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric activators of glucokinase: potential role in diabetes therapy.
    Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
    Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and regulation of glucokinase in rat islet beta- and alpha-cells during development.
    Tu J; Tuch BE; Si Z
    Endocrinology; 1999 Aug; 140(8):3762-6. PubMed ID: 10433237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A report of 2 new cases of MODY2 and review of the literature: implications in the search for type 2 diabetes drugs.
    Shammas C; Neocleous V; Phelan MM; Lian LY; Skordis N; Phylactou LA
    Metabolism; 2013 Nov; 62(11):1535-42. PubMed ID: 23890519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation.
    Yellapu NK; Valasani KR; Pasupuleti SK; Gopal S; Potukuchi Venkata Gurunadha Krishna S; Matcha B
    Biotechnol Appl Biochem; 2014; 61(5):572-81. PubMed ID: 24447076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations.
    Pino MF; Kim KA; Shelton KD; Lindner J; Odili S; Li C; Collins HW; Shiota M; Matschinsky FM; Magnuson MA
    J Biol Chem; 2007 May; 282(18):13906-16. PubMed ID: 17353190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translocation of glucokinase in pancreatic beta-cells during acute and chronic hyperglycemia.
    Noma Y; Bonner-Weir S; Latimer JB; Davalli AM; Weir GC
    Endocrinology; 1996 Apr; 137(4):1485-91. PubMed ID: 8625927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. UCP2 mRNA expression is dependent on glucose metabolism in pancreatic islets.
    Dalgaard LT
    Biochem Biophys Res Commun; 2012 Jan; 417(1):495-500. PubMed ID: 22177951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose regulates the maximal velocities of glucokinase and glucose utilization in the immature fetal rat pancreatic islet.
    Tu J; Tuch BE
    Diabetes; 1996 Aug; 45(8):1068-75. PubMed ID: 8690154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule glucokinase activators as glucose lowering agents: a new paradigm for diabetes therapy.
    Guertin KR; Grimsby J
    Curr Med Chem; 2006; 13(15):1839-43. PubMed ID: 16787225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations.
    Heredia VV; Carlson TJ; Garcia E; Sun S
    J Biol Chem; 2006 Dec; 281(52):40201-7. PubMed ID: 17082186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells.
    Cullen KS; Matschinsky FM; Agius L; Arden C
    Diabetes; 2011 Dec; 60(12):3175-85. PubMed ID: 22028181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics.
    Grewal AS; Lather V; Charaya N; Sharma N; Singh S; Kairys V
    Curr Pharm Des; 2020; 26(21):2510-2552. PubMed ID: 32286938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.